About us

Management team

Yishay Knobel

Yishay Knobel

Co-Founder & CEO

Shlomi Aflalo

Shlomi Aflalo

Co-Founder & CTO

Adam Fine

Adam Fine

Investor

Sonny Vu

Sonny Vu

Advisor

Chris Bergstrom

Chris Bergstrom

Advisor

Why we're here

Yishai and Shlomi go back to the late 90's back in an Israeli Army R&D unit. They reconnected in 2013 to start HelpAround — with the same thought: make it easy for people to rely on others so as "not to get stuck". Yishai had just developed one of the industries first mHealth apps, “iBGStar”. The app was a companion to the first iPhone glucose monitor and was licensed by Sanofi, where it became the benchmark for diabetes apps around the globe. In the meantime, Shlomi was Vice President of R&D at eXelate, a contextual and behavioral ad targeting company that was sold to Nielsen for $200 million.


Together, they decided to apply their knowledge of mobile health and data driven, targeted advertising to build a smart "safety net" for chronic patients. Similar to on-line advertising where data is used to pair buyers with sellers, Yishai and Shlomi used patient data and passive contextual data to pair patients in need with the right helper.




Adam Fine is a co-founder and CEO of Windham Venture Partners. Adam is currently a Director at GlySens, Inc., and an observer to SpineView and CuraSeal. Adam is also a mentor in Blueprint Health, a health care IT accelerator in NYC.




Sonny Vu, founder of Misfit, the maker of award-winning wearable and ambient computing products, is HelpAround's first advisor. Founder of AgaMatrix, maker of the world's 1st iPhone-connected hardware medical device, he brought the company to shipping 15+ FDA-cleared devices over a decade's work.





Chris Bergstrom is an accomplished digital health pioneer currently working for The Boston Consulting Group (BCG) as the Associate Director, Digital Health Expert. Previously Chris was the former Chief Strategy & Commercial Officer at WellDoc and held progressive positions in other healthcare start-ups, P&G, Roche, and BD. In these roles he developed and launched some of the most advanced diabetes technologies, including blood glucose systems, insulin delivery devices, and the world’s first Mobile Prescription Therapy.